RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech may rebound further after it tested the MYR1.26 support in recent sessions. Given that the stock has formed a “Hammer” pattern on 14 May, this indicates a potential rebound. A bullish bias may appear above the MYR1.34 level, with an exit set below the MYR1.26 threshold. Towards the upside, the near-term resistance is at MYR1.42. This is followed by the MYR1.50 level.
Source: RHB Securities Research - 21 May 2019
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Duopharma Biotech - Lacking Near-Term Re-Rating Catalysts; D/G NEUTRAL
Created by rhboskres | Aug 26, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-25 16:50:00
MACD/RSI
10 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 20
10 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 20
5 Mins
BUY
2024-11-25 16:50:00
TURTLE SYSTEM 55
5 Mins
BUY
2024-11-25 15:40:00
EMA 5
10 Mins
BUY
Apps
Top Articles
1
2
3
TA Sector Research
4
Good Articles to Share
Le Pen makes new threat to withdraw support for French government
5
Good Articles to Share
6
Koon Yew Yin's Blog
7
Good Articles to Share
US lawmakers say Hong Kong is becoming hub for financial crime — report
8
Good Articles to Share
Global airfares set to rise yet again in 2025, Amex report says
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
